The Impact of Generics on Pharmaceutical Growth Opportunities - A Growing Threat that Offers Future Opportunities

CBR Pharma Insights, October 2011, Pages: 53

While generic penetration has been on the rise in the major developed markets for some time, the current and continuing difficult economic environment is stimulating political and payer actions to accelerate the trend.

Combined with this, pharma is experiencing a wave of blockbuster patent expiries, with almost $30 billion in US sales (at 2010 levels) exposed by the largest 10 drugs which are expected to experience generic competition for the first time in 2011-2012.

As a result, companies must focus on optimizing their late-stage lifecycle management strategies to maximize at-risk product revenues. But at the same, time generics should be considered not just as a threat but also as an opportunity going forward.

The report, “The Impact of Generics on Pharmaceutical Growth Opportunities”, has been written to support companies with their strategic plans to maximize revenues within the shifting pharmaceutical landscape. The insights, analysis, and support provided can be used by both the branded and generics side of the business.

Key Reasons to Purchase

- Compare your company's lifecycle management strategies with those most appropriate for maximizing generic defense

- Assess the opportunities available to move into the generics side of the pharmaceutical industry, both in the established and emerging markets

- Understand the various opportunities that exist to optimize revenue in preparation for your product's patent expiry

- Benefit from the analysis of multiple case studies to help support your company's/brand's strategy moving forward

- Learn from the assessments of actual tactics companies have taken, both branded & generic, to drive future revenue growth in this new era of generics

Executive summary

The impact of generics in 2011 and beyond
- The impact of generics on the pharma market in 2010
- Key events/trends impacting generic usage in the major pharmaceutical markets
- Key patent expiries in 2011 and 2012
- Generics driving emerging market growth

Revenue optimization at patent expiry
- Pediatric exclusivity
- Strategic pricing (including coupons and co-pay cards)
- Authorized generics
- Pay for delay deals
- Citizens petitions
- Reformulation and combination drugs
- Next generation drugs
- Prescription to over-the-counter switch

Generics as an opportunity
- Big pharma with generics operations
- Emerging markets: a generics opportunity

Appendix

Customers who bought this item also bought

• Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs
• Trends Shaping U.S. Medical Devices Industry Strategies
• Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report
• Medical Nutrition - A Global Market Overview
• Generics: Global Industry Guide
• Generics: Global Industry Guide
• The 111th U.S. Congress Tackles Healthcare Reform and the Pharmaceutical Industry
• Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010
• Syringes (Disposable and Reusable) - Global Strategic Business Report
• Molecular Diagnostics - Global Strategic Business Report